Institute of Biomedical (OTC: MRES)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Institute of Biomedical (OTCPK: MRES) through any online brokerage.
There are no as such competitors for Institute of Biomedical.
The latest price target for Institute of Biomedical (OTCPK: MRES) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting MRES to rise to within 12 months (a possible 16566.67% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Institute of Biomedical (OTCPK: MRES) is $0.024 last updated August 12, 2022, 5:17 PM UTC.
The next Institute of Biomedical (MRES) dividend date is projected to be Thursday, September 1, 2022.
Institute of Biomedical’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Institute of Biomedical.
Institute of Biomedical is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.